Nevertheless, only approximately 3% of ovarian cancers are mucinous [46], some of which are due to other cancer predisposition genes that are frequently concurrently tested with BRCA1 and BRCA2. Therefore, it is the simplest to offer testing to all women with epithelial ovarian cancer [47]. The gene discussed is BRCA1; the disease is ovarian carcinoma.